Ad hoc announcement pursuant to Art. 53 LR
Originally posted here:
Santhera and ReveraGen Complete NDA Submission to FDA for Vamorolone in Duchenne Muscular Dystrophy
Recommendation and review posted by Fredricko
Search Immortality Topics: |
Posted: October 27, 2022 at 1:55 am
Ad hoc announcement pursuant to Art. 53 LR
Originally posted here:
Santhera and ReveraGen Complete NDA Submission to FDA for Vamorolone in Duchenne Muscular Dystrophy
Recommendation and review posted by Fredricko